Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to $884000.0.

  • Mesa Laboratories' Dividends Paid - Common rose 172.61% to $884000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.5 million, marking a year-over-year increase of 135.76%. This contributed to the annual value of $3.5 million for FY2025, which is 60.92% up from last year.
  • Per Mesa Laboratories' latest filing, its Dividends Paid - Common stood at $884000.0 for Q4 2025, which was up 172.61% from $882000.0 recorded in Q3 2025.
  • Mesa Laboratories' Dividends Paid - Common's 5-year high stood at $884000.0 during Q4 2025, with a 5-year trough of $824000.0 in Q1 2021.
  • Over the past 5 years, Mesa Laboratories' median Dividends Paid - Common value was $860500.0 (recorded in 2023), while the average stood at $856150.0.
  • Its Dividends Paid - Common has fluctuated over the past 5 years, first soared by 1721.19% in 2021, then surged by 46.4% in 2024.
  • Quarter analysis of 5 years shows Mesa Laboratories' Dividends Paid - Common stood at $837000.0 in 2021, then rose by 2.15% to $855000.0 in 2022, then rose by 0.82% to $862000.0 in 2023, then rose by 0.81% to $869000.0 in 2024, then rose by 1.73% to $884000.0 in 2025.
  • Its last three reported values are $884000.0 in Q4 2025, $882000.0 for Q3 2025, and $873000.0 during Q2 2025.